HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Hisanori Morimoto Selected Research
Hisanori Morimoto Research Topics
Disease
3
Immunoglobulin G4-Related Disease
03/2019 - 01/2015
2
Chronic Kidney Failure (Chronic Renal Failure)
06/2008 - 08/2003
1
Body Weight (Weight, Body)
09/2017
1
Lymphoma (Lymphomas)
03/2015
1
Rheumatoid Arthritis
03/2015
1
Lymphoproliferative Disorders (Lymphoproliferative Disorder)
03/2015
1
Amyloidosis
04/2008
1
Atherosclerotic Plaque (Atheroma)
12/2005
1
Rupture
12/2005
1
Atherosclerosis
12/2005
1
Anemia
12/2004
1
Hypercalcemia (Milk Alkali Syndrome)
11/2002
1
Bone Resorption
11/2002
1
Inflammation (Inflammations)
05/2002
1
Diverticulum
05/2002
1
Peritonitis
05/2002
1
Abscess
05/2002
1
Opportunistic Infections (Opportunistic Infection)
01/2002
1
Neoplasms (Cancer)
01/2002
1
Cytomegalovirus Infections (Inclusion Disease)
01/2002
1
Enterocolitis
01/2002
Drug/Important Bio-Agent (IBA)
2
Steroids
IBA
03/2019 - 01/2015
2
Cytokines
IBA
01/2015 - 12/2005
1
Immunoglobulin Light Chains (Immunoglobulin Light Chain)
IBA
03/2019
1
Glucocorticoids
IBA
09/2017
1
Prednisolone (Predate)
FDA Link
Generic
09/2017
1
Pharmaceutical Preparations
IBA
03/2015
1
Methotrexate (Mexate)
FDA Link
Generic
03/2015
1
RNA (Ribonucleic Acid)
IBA
01/2015
1
Immunoglobulin G (IgG)
IBA
01/2015
1
DNA (Deoxyribonucleic Acid)
IBA
01/2015
1
Albumins
IBA
06/2008
1
Interleukins
IBA
12/2005
1
Tyrosine (L-Tyrosine)
FDA Link
12/2004
1
Erythropoietin
FDA Link
12/2004
1
8-Hydroxy-2'-Deoxyguanosine
IBA
08/2003
1
Alendronate (Alendronate Sodium)
FDA Link
Generic
11/2002
1
Calcium
IBA
11/2002
1
Creatinine
IBA
11/2002
1
Monoclonal Antibodies
IBA
01/2002
1
Immunosuppressive Agents (Immunosuppressants)
IBA
01/2002
Therapy/Procedure
2
Therapeutics
03/2019 - 01/2015
2
Renal Dialysis (Hemodialysis)
04/2008 - 12/2004
1
Glycemic Control
06/2008
1
Parathyroidectomy
11/2002
1
Peritoneal Dialysis
05/2002
1
Continuous Ambulatory Peritoneal Dialysis (CAPD)
05/2002